Despite a lack of evidence of clinical benefit and substantial safety and quality concerns, an FDA advisory committee ...

The rapid growth of private equity (PE) and publicly traded corporation (PTC) ownership in hospice has raised concerns that investor-driven profit incentives may undermine care quality. Evidence on ...

Medicare Advantage (MA) has become a major source of dental coverage for older US adults. However, little is known about enrollment in plans with dental coverage or about the scope and continued ...

The August issue of Health Affairs includes articles on pharmaceutical economics, physician practice, and hospitals. Many other topics are featured, including articles in our ongoing article series.

Responding to patient-initiated portal messages is a growing source of work for physicians, yet little is known about how these messages are distributed across patients and physicians. Understanding ...

Vertical integration between Medicare Advantage (MA) plans and hospital providers is increasingly common, but little is known about how vertically integrated plans pay affiliated providers for medical ...

Physician-administered drugs and biologics account for a growing share of pharmaceutical spending, but they also generate substantial revenues for the hospitals and physician practices that acquire ...

Many details of these agreements remain undisclosed, but what we know suggests they may be less far-reaching than claimed.

Since 1971, protection against measles, mumps, and rubella has been delivered in a single combined injection. A proposal to ...

Understanding the impact of price controls on drug research and approvals of secondary indications is critical for policy ...

The current MA risk adjustment model has shortcomings, both in predictive accuracy and payment equity across the Medicare ...

Pediatrics is increasingly moving toward regionalized hub-and-spoke models organized around comprehensive “centers of ...